Newton, Massachusetts – September 2016.
NeuroHealing Pharmaceuticals, a private, clinical stage company developing innovative drug treatments for specialty indications based on repositioning neurologically active compounds, announces that the United States Patent and Trademark Office (USPTO) has issued to NeuroHealing two patents entitled ““Methods and Compositions for Decreasing Saliva Production.”
The first patent (US 9,198,897), with a patent term extension to the year 2032, covers claims to methods of using tropicamide to treat sialorrhea by administering intra-oral compositions, including a muco-adhesive thin film. The second patent (US 9,433,616) covers claims for compositions comprising tropicamide formulated for intra-oral administration for decreasing saliva production. Other patents in the family have issued in Canada (CA2593492), Australia (AU2006206252), and pending in Europe.